RetCurious
GLP-1 Enthusiast
She did everything right.
A 38-year-old teacher, newly diagnosed with type 2 diabetes, starts a GLP-1 drug in the winter. She injects on the same morning every week. She keeps the food log. She walks after dinner. Six months later her A1c has barely moved, and her endocrinologist is gently asking whether she has been taking it as prescribed.
She has. The drug is doing what it does for almost everyone. It is just not doing it for her. And until this spring, nobody in that exam room could have told her why.
A 38-year-old teacher, newly diagnosed with type 2 diabetes, starts a GLP-1 drug in the winter. She injects on the same morning every week. She keeps the food log. She walks after dinner. Six months later her A1c has barely moved, and her endocrinologist is gently asking whether she has been taking it as prescribed.
She has. The drug is doing what it does for almost everyone. It is just not doing it for her. And until this spring, nobody in that exam room could have told her why.
